000 01585 a2200445 4500
005 20250515060021.0
264 0 _c20070627
008 200706s 0 0 eng d
022 _a0816-4622
024 7 _a10.1111/j.1444-0938.2007.00126.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAlbietz, Julie
245 0 0 _aOcular therapeutics.
_h[electronic resource]
260 _bClinical & experimental optometry
_cMar 2007
300 _a141-2 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdenoviridae Infections
_xdiagnosis
650 0 4 _aAdministration, Topical
650 0 4 _aAnti-Bacterial Agents
_xtherapeutic use
650 0 4 _aAzithromycin
_xtherapeutic use
650 0 4 _aBacterial Infections
_xdrug therapy
650 0 4 _aClinical Trials, Phase I as Topic
650 0 4 _aConjunctivitis
_xmicrobiology
650 0 4 _aCorneal Ulcer
_xdrug therapy
650 0 4 _aDexamethasone
_xtherapeutic use
650 0 4 _aDiagnostic Techniques, Ophthalmological
650 0 4 _aDrug Combinations
650 0 4 _aDrug Delivery Systems
650 0 4 _aEye Diseases
_xdiagnosis
650 0 4 _aGlucocorticoids
_xtherapeutic use
650 0 4 _aHumans
650 0 4 _aPhenytoin
_xadministration & dosage
650 0 4 _aSclera
650 0 4 _aUnited States
650 0 4 _aUnited States Food and Drug Administration
700 1 _aDouglas, Ian
700 1 _aNapper, Genevieve
773 0 _tClinical & experimental optometry
_gvol. 90
_gno. 2
_gp. 141-2
856 4 0 _uhttps://doi.org/10.1111/j.1444-0938.2007.00126.x
_zAvailable from publisher's website
999 _c16870341
_d16870341